(Q34661975)

3 August 2017

Statin use in patients with cirrhosis: a retrospective cohort study (English)

1 reference

3 August 2017

Sonal Kumar

1

1 reference

3 August 2017

Norman D Grace

series ordinal

2

1 reference

3 August 2017

Amir A Qamar

series ordinal

3

1 reference

3 August 2017

18 May 2014

1 reference

Digestive Diseases and Sciences

3 August 2017

1 reference

3 August 2017

59

1 reference

3 August 2017

8

1 reference

3 August 2017

1958-1965

1 reference

https://scigraph.springernature.com/pub.10.1007/s10620-014-3179-2

3 August 2017

0 references

cites work

Hyperlipidaemic state and cardiovascular risk in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3179-2

Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: an open question.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3179-2

Coronary artery disease in patients with liver cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3179-2

Cardiovascular risk assessment of the liver transplant candidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3179-2

Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3179-2

Statin use is associated with prolonged survival of renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3179-2

Statins and the risk of cancer after heart transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3179-2

Effect of statin treatment on short term mortality after pneumonia episode: cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3179-2

Statins and the risk of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3179-2

The association between 3-hydroxy-3-methylglutaryl conenzyme A inhibitor use and breast carcinoma risk among postmenopausal women: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3179-2

Cancer risk among statin users: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3179-2

Statin use and fatal prostate cancer: a matched case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3179-2

Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3179-2

Statins and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3179-2

Statins: mechanism of action and effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3179-2

Hepatotoxicity of hypolipidemic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3179-2

Statins in the treatment of dyslipidemia in the presence of elevated liver aminotransferase levels: a therapeutic dilemma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3179-2

Statins in liver disease: a molehill, an iceberg, or neither?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3179-2

Patients with elevated baseline liver enzymes do not have higher frequency of hepatotoxicity from lovastatin than those with normal baseline liver enzymes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3179-2

Statins and hepatotoxicity: focus on patients with fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3179-2

Safety of statin therapy in patients with preexisting liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3179-2

Incidence of statin hepatotoxicity in patients with hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3179-2

Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3179-2

Hepatic effects of lovastatin exposure in patients with liver disease: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3179-2

Clinical perspective: statins and the liver--harmful or helpful?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3179-2

Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3179-2

Simvastatin enhances hepatic nitric oxide production and decreases the hepatic vascular tone in patients with cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3179-2

Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3179-2

Atorvastatin attenuates angiotensin II-induced inflammatory actions in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3179-2

Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3179-2

Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3179-2

Differences and similarities in early atherosclerosis between patients with non-alcoholic steatohepatitis and chronic hepatitis B and C

21 January 2018

1 reference

12 December 2020

Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis

1 reference

12 December 2020

Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial

1 reference

12 December 2020

Cardiac hemodynamic and coronary angiographic characteristics of patients being evaluated for liver transplantation

1 reference

12 December 2020

An assessment of statin safety by hepatologists

1 reference

12 December 2020

How to use statins in patients with chronic liver disease

1 reference

12 December 2020

Prolonging survival in patients with cirrhosis: old drugs with new indications

1 reference

12 December 2020

10.1007/S10620-014-3179-2

Identifiers

DOI

1 reference

Dimensions Publication ID

3 August 2017

1022665813

0 references

Fatcat ID

release_uf5dywvxbjcu5aqm6vu67zshim

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/uf5dywvxbjcu5aqm6vu67zshim

24 November 2022

mapped directly with Wikidata item

1 reference